|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:AUTS2-PNLIPRP3 (FusionGDB2 ID:8512) |
Fusion Gene Summary for AUTS2-PNLIPRP3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AUTS2-PNLIPRP3 | Fusion gene ID: 8512 | Hgene | Tgene | Gene symbol | AUTS2 | PNLIPRP3 | Gene ID | 26053 | 119548 |
| Gene name | activator of transcription and developmental regulator AUTS2 | pancreatic lipase related protein 3 | |
| Synonyms | FBRSL2|MRD26 | - | |
| Cytomap | 7q11.22 | 10q25.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | autism susceptibility gene 2 proteinAUTS2, activator of transcription and developmental regulatorautism susceptibility candidate 2autism-related protein 1 | pancreatic lipase-related protein 3PL-RP3 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q8WXX7 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000342771, ENST00000403018, ENST00000406775, ENST00000489774, | ENST00000369230, | |
| Fusion gene scores | * DoF score | 29 X 23 X 8=5336 | 2 X 2 X 2=8 |
| # samples | 30 | 2 | |
| ** MAII score | log2(30/5336*10)=-4.1527242606887 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
| Context | PubMed: AUTS2 [Title/Abstract] AND PNLIPRP3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | AUTS2(69364484)-PNLIPRP3(118215234), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | AUTS2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 25519132 |
| Hgene | AUTS2 | GO:0051571 | positive regulation of histone H3-K4 methylation | 25519132 |
| Hgene | AUTS2 | GO:2000620 | positive regulation of histone H4-K16 acetylation | 25519132 |
| Fusion gene breakpoints across AUTS2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across PNLIPRP3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | OV | TCGA-13-0916-01A | AUTS2 | chr7 | 69364484 | - | PNLIPRP3 | chr10 | 118215234 | + |
| ChimerDB4 | OV | TCGA-13-0916-01A | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + |
Top |
Fusion Gene ORF analysis for AUTS2-PNLIPRP3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000342771 | ENST00000369230 | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + |
| In-frame | ENST00000403018 | ENST00000369230 | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + |
| In-frame | ENST00000406775 | ENST00000369230 | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + |
| intron-3CDS | ENST00000489774 | ENST00000369230 | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000406775 | AUTS2 | chr7 | 69364484 | + | ENST00000369230 | PNLIPRP3 | chr10 | 118215234 | + | 3009 | 1257 | 735 | 2204 | 489 |
| ENST00000342771 | AUTS2 | chr7 | 69364484 | + | ENST00000369230 | PNLIPRP3 | chr10 | 118215234 | + | 2595 | 843 | 321 | 1790 | 489 |
| ENST00000403018 | AUTS2 | chr7 | 69364484 | + | ENST00000369230 | PNLIPRP3 | chr10 | 118215234 | + | 2317 | 565 | 43 | 1512 | 489 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000406775 | ENST00000369230 | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + | 0.0022588 | 0.9977412 |
| ENST00000342771 | ENST00000369230 | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + | 0.002003619 | 0.9979964 |
| ENST00000403018 | ENST00000369230 | AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215234 | + | 0.001373065 | 0.99862695 |
Top |
Fusion Genomic Features for AUTS2-PNLIPRP3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215233 | + | 0.000129799 | 0.9998702 |
| AUTS2 | chr7 | 69364484 | + | PNLIPRP3 | chr10 | 118215233 | + | 0.000129799 | 0.9998702 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for AUTS2-PNLIPRP3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr7:69364484/chr10:118215234) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AUTS2 | . |
| FUNCTION: Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:25519132). The PRC1-like complex that contains PCGF5, RNF2, CSNK2B, RYBP and AUTS2 has decreased histone H2A ubiquitination activity, due to the phosphorylation of RNF2 by CSNK2B (PubMed:25519132). As a consequence, the complex mediates transcriptional activation (PubMed:25519132). In the cytoplasm, plays a role in axon and dendrite elongation and in neuronal migration during embryonic brain development. Promotes reorganization of the actin cytoskeleton, lamellipodia formation and neurite elongation via its interaction with RAC guanine nucleotide exchange factors, which then leads to the activation of RAC1 (By similarity). {ECO:0000250|UniProtKB:A0A087WPF7, ECO:0000269|PubMed:25519132}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | PNLIPRP3 | chr7:69364484 | chr10:118215234 | ENST00000369230 | 3 | 12 | 355_467 | 152 | 468.0 | Domain | Note=PLAT |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000342771 | + | 2 | 19 | 1122_1181 | 174 | 1260.0 | Compositional bias | His-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000342771 | + | 2 | 19 | 288_471 | 174 | 1260.0 | Compositional bias | Pro-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000342771 | + | 2 | 19 | 525_548 | 174 | 1260.0 | Compositional bias | His-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000342771 | + | 2 | 19 | 545_646 | 174 | 1260.0 | Compositional bias | Pro-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000403018 | + | 2 | 5 | 1122_1181 | 174 | 267.0 | Compositional bias | His-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000403018 | + | 2 | 5 | 288_471 | 174 | 267.0 | Compositional bias | Pro-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000403018 | + | 2 | 5 | 525_548 | 174 | 267.0 | Compositional bias | His-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000403018 | + | 2 | 5 | 545_646 | 174 | 267.0 | Compositional bias | Pro-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000406775 | + | 2 | 18 | 1122_1181 | 174 | 1236.0 | Compositional bias | His-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000406775 | + | 2 | 18 | 288_471 | 174 | 1236.0 | Compositional bias | Pro-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000406775 | + | 2 | 18 | 525_548 | 174 | 1236.0 | Compositional bias | His-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000406775 | + | 2 | 18 | 545_646 | 174 | 1236.0 | Compositional bias | Pro-rich |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000342771 | + | 2 | 19 | 289_472 | 174 | 1260.0 | Region | Important for regulation of lamellipodia formation |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000403018 | + | 2 | 5 | 289_472 | 174 | 267.0 | Region | Important for regulation of lamellipodia formation |
| Hgene | AUTS2 | chr7:69364484 | chr10:118215234 | ENST00000406775 | + | 2 | 18 | 289_472 | 174 | 1236.0 | Region | Important for regulation of lamellipodia formation |
Top |
Fusion Gene Sequence for AUTS2-PNLIPRP3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >8512_8512_1_AUTS2-PNLIPRP3_AUTS2_chr7_69364484_ENST00000342771_PNLIPRP3_chr10_118215234_ENST00000369230_length(transcript)=2595nt_BP=843nt CTGTGTGTTCAGCCATTACTTTGCTCGGCGCTGCTCCCAGGCATCTCCGACCCTCGGTGCTGTGGGGAGCCCCACACTTGGGCTCCTCGC CTCTCGCCCTCGCTCCCCGTCCCTCCTCCCCTCTCTCCGCCCCTTCCCCCTTTTCTTTCTCCTCTCTTTCTTCCCCTCTCTCCCTTCTTT CGGCCGCCGTCTCCCCCGCGCCCTCCTCGGGGCGGAGGGAAGCCGTGAAGGGGGAGGGAGGGCTCGGTGTCAATTTTTTTTTGTGTGGCT GCGGCCGTAGCCTGTGGCGGGCAAGCGGGGAGACCCCGGCGCAGCAGAACCATGGATGGCCCGACGCGGGGCCATGGACTCCGCAAAAAG CGGCGGTCGCGGTCGCAGCGAGACCGGGAGAGGCGCTCCCGGGGCGGGCTGGGGGCCGGCGCGGCCGGCGGCGGCGGGGCTGGCCGGACC CGGGCGCTCTCACTCGCCTCGTCGTCGGGCTCCGACAAGGAAGACAATGGGAAGCCCCCGTCCTCCGCCCCGTCCCGGCCCAGACCCCCG CGGAGGAAGCGGAGAGAGTCCACCTCGGCAGAAGAGGACATCATTGATGGATTTGCCATGACCAGCTTTGTCACTTTTGAAGCGCTGGAG AAAGATGTAGCACTTAAGCCTCAGGAACGTGTGGAGAAACGCCAGACGCCCCTGACCAAGAAGAAACGAGAAGCACTTACCAATGGCTTG TCCTTTCATTCAAAGAAGAGCAGACTCAGCCACCCACACCACTACAGCTCAGATCGAGAAAATGACCGCAATCTCTGCCAGCACCTTGGG AAGAGAAAGAAAATGCCGAAGGCACTCAGACAGAAAAAATTTGAATATTCCCCTTCTAAAGTGCACTTGATTGGCCACAGCTTGGGAGCA CACCTGGCTGGGGAAGCTGGGTCAAGGATACCAGGCCTTGGAAGAATAACTGGGTTGGACCCAGCTGGGCCATTTTTCCACAACACTCCA AAGGAAGTCAGGCTAGACCCCTCGGATGCCAACTTTGTTGACGTTATTCATACAAATGCAGCTCGCATCCTCTTTGAGCTTGGTGTTGGA ACCATTGATGCTTGTGGTCATCTTGACTTTTACCCAAATGGAGGGAAGCACATGCCAGGATGTGAAGACTTAATTACACCTTTACTGAAA TTTAACTTCAATGCTTACAAAAAAGAAATGGCTTCCTTCTTTGACTGTAACCATGCCCGAAGTTATCAATTTTATGCTGAAAGCATTCTT AATCCTGATGCATTTATTGCTTATCCTTGTAGATCCTACACATCTTTTAAAGCAGGAAATTGCTTCTTTTGTTCCAAAGAAGGTTGCCCA ACAATGGGTCATTTTGCTGATAGATTTCACTTCAAAAATATGAAGACTAATGGATCACATTATTTTTTAAACACAGGGTCCCTTTCCCCA TTTGCCCGTTGGAGGCACAAATTGTCTGTTAAACTCAGTGGAAGCGAAGTCACTCAAGGAACTGTCTTTCTTCGTGTAGGCGGGGCAGTT AGGAAAACTGGGGAGTTTGCCATTGTCAGTGGAAAACTTGAGCCAGGCATGACTTACACAAAATTAATCGATGCAGATGTTAACGTTGGA AACATTACAAGTGTTCAGTTCATCTGGAAAAAACATTTGTTTGAAGATTCTCAGAATAAGTTGGGAGCAGAAATGGTGATAAATACATCT GGGAAATATGGATATAAATCTACCTTCTGTAGCCAAGACATTATGGGACCTAATATTCTCCAGAACCTGAAACCATGCTAATCTCAGATA CAGTCTTGATGGATTTCTTTAGTAGGAGCAATGAAGAAAAGTGTCTCCTTCCACCTGGCATCCAGACCAAATTTGACCCTTGTAAATGAC TTAGTCATTTACAAGGGTCTTACTCAGAGTCAAGTACGGGTTTGCTTTTTTTCTGTGTAGAATGTTCATCTAACTGCACCTTAAAAACAC ACTGAACCCTGGGACAAAAGATAATTACTATGATCTGTAGGAATCTGGATATCATTGACAAAATAGAGCTGTTTTGGAATTTTCCTGAAT AAGAGGAGGTGATGCAAATGTATGTTGAGTGTATAAACTCACTGGACAAAAGTAAGCCTCTGGCTTGCTGAGTTTTTGAAGTATATTTTC AGGTATAATAATCATTGTTCTAAAATTATATAAAACTATTTGTTATGTTGTTAAATCTTGCTGAGACAAATTATGACTATAGTGCATGAT ATATAGTAGATTATAACCTTGTGGGTTGATGTGTCTATCTAGTAATAATAAAAACTAATGAGATGGCACTAGTATTTCCAAGGTGTTCCT TGGTGTTCAGGGTGTGCACAAGAGAGATTTTGGAGCTTATCTGTTATGTGTTCATCAGTTAGCAATGGGACCTGAAGTTCAACAACCCAG GGTATAGCCCCCTTCCTCCAAAGTCCCTGCCACAGGAGAATTACTCCTCTCCCTGGGTCTTGAATGCTCTATGGTGAATTTGTATTTAGC >8512_8512_1_AUTS2-PNLIPRP3_AUTS2_chr7_69364484_ENST00000342771_PNLIPRP3_chr10_118215234_ENST00000369230_length(amino acids)=489AA_BP=173 MDGPTRGHGLRKKRRSRSQRDRERRSRGGLGAGAAGGGGAGRTRALSLASSSGSDKEDNGKPPSSAPSRPRPPRRKRRESTSAEEDIIDG FAMTSFVTFEALEKDVALKPQERVEKRQTPLTKKKREALTNGLSFHSKKSRLSHPHHYSSDRENDRNLCQHLGKRKKMPKALRQKKFEYS PSKVHLIGHSLGAHLAGEAGSRIPGLGRITGLDPAGPFFHNTPKEVRLDPSDANFVDVIHTNAARILFELGVGTIDACGHLDFYPNGGKH MPGCEDLITPLLKFNFNAYKKEMASFFDCNHARSYQFYAESILNPDAFIAYPCRSYTSFKAGNCFFCSKEGCPTMGHFADRFHFKNMKTN GSHYFLNTGSLSPFARWRHKLSVKLSGSEVTQGTVFLRVGGAVRKTGEFAIVSGKLEPGMTYTKLIDADVNVGNITSVQFIWKKHLFEDS -------------------------------------------------------------- >8512_8512_2_AUTS2-PNLIPRP3_AUTS2_chr7_69364484_ENST00000403018_PNLIPRP3_chr10_118215234_ENST00000369230_length(transcript)=2317nt_BP=565nt AGCCTGTGGCGGGCAAGCGGGGAGACCCCGGCGCAGCAGAACCATGGATGGCCCGACGCGGGGCCATGGACTCCGCAAAAAGCGGCGGTC GCGGTCGCAGCGAGACCGGGAGAGGCGCTCCCGGGGCGGGCTGGGGGCCGGCGCGGCCGGCGGCGGCGGGGCTGGCCGGACCCGGGCGCT CTCACTCGCCTCGTCGTCGGGCTCCGACAAGGAAGACAATGGGAAGCCCCCGTCCTCCGCCCCGTCCCGGCCCAGACCCCCGCGGAGGAA GCGGAGAGAGTCCACCTCGGCAGAAGAGGACATCATTGATGGATTTGCCATGACCAGCTTTGTCACTTTTGAAGCGCTGGAGAAAGATGT AGCACTTAAGCCTCAGGAACGTGTGGAGAAACGCCAGACGCCCCTGACCAAGAAGAAACGAGAAGCACTTACCAATGGCTTGTCCTTTCA TTCAAAGAAGAGCAGACTCAGCCACCCACACCACTACAGCTCAGATCGAGAAAATGACCGCAATCTCTGCCAGCACCTTGGGAAGAGAAA GAAAATGCCGAAGGCACTCAGACAGAAAAAATTTGAATATTCCCCTTCTAAAGTGCACTTGATTGGCCACAGCTTGGGAGCACACCTGGC TGGGGAAGCTGGGTCAAGGATACCAGGCCTTGGAAGAATAACTGGGTTGGACCCAGCTGGGCCATTTTTCCACAACACTCCAAAGGAAGT CAGGCTAGACCCCTCGGATGCCAACTTTGTTGACGTTATTCATACAAATGCAGCTCGCATCCTCTTTGAGCTTGGTGTTGGAACCATTGA TGCTTGTGGTCATCTTGACTTTTACCCAAATGGAGGGAAGCACATGCCAGGATGTGAAGACTTAATTACACCTTTACTGAAATTTAACTT CAATGCTTACAAAAAAGAAATGGCTTCCTTCTTTGACTGTAACCATGCCCGAAGTTATCAATTTTATGCTGAAAGCATTCTTAATCCTGA TGCATTTATTGCTTATCCTTGTAGATCCTACACATCTTTTAAAGCAGGAAATTGCTTCTTTTGTTCCAAAGAAGGTTGCCCAACAATGGG TCATTTTGCTGATAGATTTCACTTCAAAAATATGAAGACTAATGGATCACATTATTTTTTAAACACAGGGTCCCTTTCCCCATTTGCCCG TTGGAGGCACAAATTGTCTGTTAAACTCAGTGGAAGCGAAGTCACTCAAGGAACTGTCTTTCTTCGTGTAGGCGGGGCAGTTAGGAAAAC TGGGGAGTTTGCCATTGTCAGTGGAAAACTTGAGCCAGGCATGACTTACACAAAATTAATCGATGCAGATGTTAACGTTGGAAACATTAC AAGTGTTCAGTTCATCTGGAAAAAACATTTGTTTGAAGATTCTCAGAATAAGTTGGGAGCAGAAATGGTGATAAATACATCTGGGAAATA TGGATATAAATCTACCTTCTGTAGCCAAGACATTATGGGACCTAATATTCTCCAGAACCTGAAACCATGCTAATCTCAGATACAGTCTTG ATGGATTTCTTTAGTAGGAGCAATGAAGAAAAGTGTCTCCTTCCACCTGGCATCCAGACCAAATTTGACCCTTGTAAATGACTTAGTCAT TTACAAGGGTCTTACTCAGAGTCAAGTACGGGTTTGCTTTTTTTCTGTGTAGAATGTTCATCTAACTGCACCTTAAAAACACACTGAACC CTGGGACAAAAGATAATTACTATGATCTGTAGGAATCTGGATATCATTGACAAAATAGAGCTGTTTTGGAATTTTCCTGAATAAGAGGAG GTGATGCAAATGTATGTTGAGTGTATAAACTCACTGGACAAAAGTAAGCCTCTGGCTTGCTGAGTTTTTGAAGTATATTTTCAGGTATAA TAATCATTGTTCTAAAATTATATAAAACTATTTGTTATGTTGTTAAATCTTGCTGAGACAAATTATGACTATAGTGCATGATATATAGTA GATTATAACCTTGTGGGTTGATGTGTCTATCTAGTAATAATAAAAACTAATGAGATGGCACTAGTATTTCCAAGGTGTTCCTTGGTGTTC AGGGTGTGCACAAGAGAGATTTTGGAGCTTATCTGTTATGTGTTCATCAGTTAGCAATGGGACCTGAAGTTCAACAACCCAGGGTATAGC CCCCTTCCTCCAAAGTCCCTGCCACAGGAGAATTACTCCTCTCCCTGGGTCTTGAATGCTCTATGGTGAATTTGTATTTAGCCTCAAGGC >8512_8512_2_AUTS2-PNLIPRP3_AUTS2_chr7_69364484_ENST00000403018_PNLIPRP3_chr10_118215234_ENST00000369230_length(amino acids)=489AA_BP=173 MDGPTRGHGLRKKRRSRSQRDRERRSRGGLGAGAAGGGGAGRTRALSLASSSGSDKEDNGKPPSSAPSRPRPPRRKRRESTSAEEDIIDG FAMTSFVTFEALEKDVALKPQERVEKRQTPLTKKKREALTNGLSFHSKKSRLSHPHHYSSDRENDRNLCQHLGKRKKMPKALRQKKFEYS PSKVHLIGHSLGAHLAGEAGSRIPGLGRITGLDPAGPFFHNTPKEVRLDPSDANFVDVIHTNAARILFELGVGTIDACGHLDFYPNGGKH MPGCEDLITPLLKFNFNAYKKEMASFFDCNHARSYQFYAESILNPDAFIAYPCRSYTSFKAGNCFFCSKEGCPTMGHFADRFHFKNMKTN GSHYFLNTGSLSPFARWRHKLSVKLSGSEVTQGTVFLRVGGAVRKTGEFAIVSGKLEPGMTYTKLIDADVNVGNITSVQFIWKKHLFEDS -------------------------------------------------------------- >8512_8512_3_AUTS2-PNLIPRP3_AUTS2_chr7_69364484_ENST00000406775_PNLIPRP3_chr10_118215234_ENST00000369230_length(transcript)=3009nt_BP=1257nt CGCTCGCAGTTTCGCCCTCTCTTCCGCTAATGATTGCATTATTATGCTCCCCTCTCTGGGGGGTCTCGCCCCTCTTGGGTCGCTCCGGAG CCCCGGCCTCCCCTGGCTGCATTTCTTAAAAATTTGGGAGCCTGGGAGTGAGTTTTCTCCGAGGCGTGTGTGAGAGGCGGCGGGGGTGTT TTCCTGCGCGAGGGGCGGGTGAAGTTCATTGCCCCCACTTTTCCCGCGACCTTTTTCGGACCCGATTTTGGATCGAGTTGAGGGGGGCGC GGGCGTTTTCGGGGGGCGGGGGGCGCGGCGGAGAATGGCCGCGGGGAGGGCTCCCCGGAGCCTCCCAGTCTCTTGATCAAAGCATTCCGC TATTCTGATTTATTGCTTGCTTGGTGAGTTATTTTTTTTTCCTCTAAAGGAGACCTGTGTGTTCAGCCATTACTTTGCTCGGCGCTGCTC CCAGGCATCTCCGACCCTCGGTGCTGTGGGGAGCCCCACACTTGGGCTCCTCGCCTCTCGCCCTCGCTCCCCGTCCCTCCTCCCCTCTCT CCGCCCCTTCCCCCTTTTCTTTCTCCTCTCTTTCTTCCCCTCTCTCCCTTCTTTCGGCCGCCGTCTCCCCCGCGCCCTCCTCGGGGCGGA GGGAAGCCGTGAAGGGGGAGGGAGGGCTCGGTGTCAATTTTTTTTTGTGTGGCTGCGGCCGTAGCCTGTGGCGGGCAAGCGGGGAGACCC CGGCGCAGCAGAACCATGGATGGCCCGACGCGGGGCCATGGACTCCGCAAAAAGCGGCGGTCGCGGTCGCAGCGAGACCGGGAGAGGCGC TCCCGGGGCGGGCTGGGGGCCGGCGCGGCCGGCGGCGGCGGGGCTGGCCGGACCCGGGCGCTCTCACTCGCCTCGTCGTCGGGCTCCGAC AAGGAAGACAATGGGAAGCCCCCGTCCTCCGCCCCGTCCCGGCCCAGACCCCCGCGGAGGAAGCGGAGAGAGTCCACCTCGGCAGAAGAG GACATCATTGATGGATTTGCCATGACCAGCTTTGTCACTTTTGAAGCGCTGGAGAAAGATGTAGCACTTAAGCCTCAGGAACGTGTGGAG AAACGCCAGACGCCCCTGACCAAGAAGAAACGAGAAGCACTTACCAATGGCTTGTCCTTTCATTCAAAGAAGAGCAGACTCAGCCACCCA CACCACTACAGCTCAGATCGAGAAAATGACCGCAATCTCTGCCAGCACCTTGGGAAGAGAAAGAAAATGCCGAAGGCACTCAGACAGAAA AAATTTGAATATTCCCCTTCTAAAGTGCACTTGATTGGCCACAGCTTGGGAGCACACCTGGCTGGGGAAGCTGGGTCAAGGATACCAGGC CTTGGAAGAATAACTGGGTTGGACCCAGCTGGGCCATTTTTCCACAACACTCCAAAGGAAGTCAGGCTAGACCCCTCGGATGCCAACTTT GTTGACGTTATTCATACAAATGCAGCTCGCATCCTCTTTGAGCTTGGTGTTGGAACCATTGATGCTTGTGGTCATCTTGACTTTTACCCA AATGGAGGGAAGCACATGCCAGGATGTGAAGACTTAATTACACCTTTACTGAAATTTAACTTCAATGCTTACAAAAAAGAAATGGCTTCC TTCTTTGACTGTAACCATGCCCGAAGTTATCAATTTTATGCTGAAAGCATTCTTAATCCTGATGCATTTATTGCTTATCCTTGTAGATCC TACACATCTTTTAAAGCAGGAAATTGCTTCTTTTGTTCCAAAGAAGGTTGCCCAACAATGGGTCATTTTGCTGATAGATTTCACTTCAAA AATATGAAGACTAATGGATCACATTATTTTTTAAACACAGGGTCCCTTTCCCCATTTGCCCGTTGGAGGCACAAATTGTCTGTTAAACTC AGTGGAAGCGAAGTCACTCAAGGAACTGTCTTTCTTCGTGTAGGCGGGGCAGTTAGGAAAACTGGGGAGTTTGCCATTGTCAGTGGAAAA CTTGAGCCAGGCATGACTTACACAAAATTAATCGATGCAGATGTTAACGTTGGAAACATTACAAGTGTTCAGTTCATCTGGAAAAAACAT TTGTTTGAAGATTCTCAGAATAAGTTGGGAGCAGAAATGGTGATAAATACATCTGGGAAATATGGATATAAATCTACCTTCTGTAGCCAA GACATTATGGGACCTAATATTCTCCAGAACCTGAAACCATGCTAATCTCAGATACAGTCTTGATGGATTTCTTTAGTAGGAGCAATGAAG AAAAGTGTCTCCTTCCACCTGGCATCCAGACCAAATTTGACCCTTGTAAATGACTTAGTCATTTACAAGGGTCTTACTCAGAGTCAAGTA CGGGTTTGCTTTTTTTCTGTGTAGAATGTTCATCTAACTGCACCTTAAAAACACACTGAACCCTGGGACAAAAGATAATTACTATGATCT GTAGGAATCTGGATATCATTGACAAAATAGAGCTGTTTTGGAATTTTCCTGAATAAGAGGAGGTGATGCAAATGTATGTTGAGTGTATAA ACTCACTGGACAAAAGTAAGCCTCTGGCTTGCTGAGTTTTTGAAGTATATTTTCAGGTATAATAATCATTGTTCTAAAATTATATAAAAC TATTTGTTATGTTGTTAAATCTTGCTGAGACAAATTATGACTATAGTGCATGATATATAGTAGATTATAACCTTGTGGGTTGATGTGTCT ATCTAGTAATAATAAAAACTAATGAGATGGCACTAGTATTTCCAAGGTGTTCCTTGGTGTTCAGGGTGTGCACAAGAGAGATTTTGGAGC TTATCTGTTATGTGTTCATCAGTTAGCAATGGGACCTGAAGTTCAACAACCCAGGGTATAGCCCCCTTCCTCCAAAGTCCCTGCCACAGG AGAATTACTCCTCTCCCTGGGTCTTGAATGCTCTATGGTGAATTTGTATTTAGCCTCAAGGCAGCATTTCATTTGTAAAGCACTTGGGTA >8512_8512_3_AUTS2-PNLIPRP3_AUTS2_chr7_69364484_ENST00000406775_PNLIPRP3_chr10_118215234_ENST00000369230_length(amino acids)=489AA_BP=173 MDGPTRGHGLRKKRRSRSQRDRERRSRGGLGAGAAGGGGAGRTRALSLASSSGSDKEDNGKPPSSAPSRPRPPRRKRRESTSAEEDIIDG FAMTSFVTFEALEKDVALKPQERVEKRQTPLTKKKREALTNGLSFHSKKSRLSHPHHYSSDRENDRNLCQHLGKRKKMPKALRQKKFEYS PSKVHLIGHSLGAHLAGEAGSRIPGLGRITGLDPAGPFFHNTPKEVRLDPSDANFVDVIHTNAARILFELGVGTIDACGHLDFYPNGGKH MPGCEDLITPLLKFNFNAYKKEMASFFDCNHARSYQFYAESILNPDAFIAYPCRSYTSFKAGNCFFCSKEGCPTMGHFADRFHFKNMKTN GSHYFLNTGSLSPFARWRHKLSVKLSGSEVTQGTVFLRVGGAVRKTGEFAIVSGKLEPGMTYTKLIDADVNVGNITSVQFIWKKHLFEDS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for AUTS2-PNLIPRP3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AUTS2-PNLIPRP3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for AUTS2-PNLIPRP3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies